Pelargonium sidoides
A South African herb clinically proven to treat acute bronchitis and other respiratory infections.
Also known as: Umckaloabo • South African Geranium
Overview
Pelargonium sidoides is a species of geranium native to South Africa. Its root extract has a long history of use in traditional medicine for coughs and respiratory ailments. It works through a unique combination of antiviral, antibacterial, and expectorant actions.
Key Benefits
Treats Acute Bronchitis
Numerous high-quality studies have confirmed its effectiveness in reducing the severity and duration of acute bronchitis.
Antiviral and Antibacterial
Prevents bacteria and viruses from attaching to cells in the respiratory tract and helps the body clear them.
Expectorant Properties
Acts as a mucolytic, helping to thin and loosen mucus, making coughs more productive and clearing the airways.
Dosage & How to Take
The standard dose of the EPs 7630 extract is 30 drops (1.5 mL) three times a day for adults.
| Purpose | Dose | Notes |
|---|---|---|
| Acute Bronchitis/Sinusitis | 1.5 mL of liquid extract 3x/day | Typically used for 7-14 days. Continue for 1-2 days after symptoms resolve to prevent relapse. |
Best Time to Take
Best taken 30 minutes before or after meals.
With or Without Food
Preferably taken without food.
Forms & Bioavailability
| Form | Absorption | Best For | Notes |
|---|---|---|---|
| EPs 7630 Liquid Extract | High | Clinically validated respiratory support | This is the specific, proprietary extract used in the vast majority of clinical research (e.g., Umcka®). |
Side Effects & Safety
Common
- Generally very well tolerated.
Rare
- Mild gastrointestinal upset.
- Allergic skin reactions.
Contraindications
- Autoimmune diseases. Pregnancy and lactation due to lack of data. Use with caution in severe liver or kidney disease.
Interactions
Theoretically may increase bleeding risk due to its coumarin content, though no cases have been reported.
Scientific Research
Efficacy and tolerability of EPs 7630 in patients with acute bronchitis: a randomised, double-blind, placebo-controlled trial
EPs 7630 was shown to be effective and well-tolerated in the treatment of acute bronchitis, significantly reducing symptom severity compared to placebo.
Food Sources
Frequently Asked Questions
Medical Disclaimer
This content is for educational and informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen, especially if you have pre-existing health conditions or are taking medications. The statements on this page have not been evaluated by the Food and Drug Administration.